SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002716
Filing Date
2020-04-29
Accepted
2020-04-29 17:23:24
Documents
6
Period of Report
2020-06-25
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241507zdef14a.htm DEF 14A 628055
2 G150899.JPG g150899.jpg GRAPHIC 11755
3 G28654.JPG g28654.jpg GRAPHIC 6567
4 G407006.JPG g407006.jpg GRAPHIC 5158
5 G20222CAI001.JPG g20222cai001.jpg GRAPHIC 148734
6 G20222CAI002.JPG g20222cai002.jpg GRAPHIC 145997
  Complete submission text file 0001047469-20-002716.txt   1067955
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 20831806
SIC: 2834 Pharmaceutical Preparations